Browse by UCL people
Group by: Type | Date
Number of items: 164.
2024
Englman, C;
Barrett, T;
Moore, CM;
Giganti, F;
(2024)
Active Surveillance for Prostate Cancer: Expanding the Role of MR Imaging and the Use of PRECISE Criteria.
Radiologic Clinics of North America
, 62
(1)
pp. 69-92.
10.1016/j.rcl.2023.06.009.
|
|
Koelker, M;
Labban, M;
Frego, N;
Ye, J;
Lipsitz, SR;
Hubbell, HT;
Edelen, M;
... Trinh, QD; + view all
(2024)
Racial differences in patient-reported outcomes among men treated with radical prostatectomy for prostate cancer.
The Prostate
, 84
(1)
pp. 47-55.
10.1002/pros.24624.
|
 |
2023
|
Asif, Aqua;
Nathan, Arjun;
Ng, Alexander;
Khetrapal, Pramit;
Chan, Vinson Wai-Shun;
Giganti, Francesco;
Allen, Clare;
... PRIME Trial Group; + view all
(2023)
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol.
BMJ Open
, 13
(4)
, Article e070280. 10.1136/bmjopen-2022-070280.
|
|
Cole, AP;
Koelker, M;
Makanjuola, J;
Moore, CM;
(2023)
Can PROMs improve racial equity in outcomes after prostatectomy?
Nature Reviews Urology
, 20
pp. 125-126.
10.1038/s41585-022-00682-2.
|
|
Giganti, Francesco;
Ng, Alexander;
Asif, Aqua;
Chan, Vinson Wai-Shun;
Rossiter, Marimo;
Nathan, Arjun;
Khetrapal, Pramit;
... PRIME Quality Improvement Group; + view all
(2023)
Global Variation in Magnetic Resonance Imaging Quality of the Prostate.
Radiology
, 309
(1)
, Article e231130. 10.1148/radiol.231130.
|
|
|
Koelker, M;
Labban, M;
Frego, N;
Meyer, CP;
Salomon, G;
Lipsitz, SR;
Withington, J;
... Cole, AP; + view all
(2023)
Contemporary patterns of local ablative therapies for prostate cancer at United States cancer centers: results from a national registry.
World Journal of Urology
, 41
(5)
pp. 1309-1315.
10.1007/s00345-023-04354-7.
|
|
Light, Alexander;
Peters, Max;
Reddy, Deepika;
Kanthabalan, Abi;
Otieno, Marjorie;
Pavlou, Menelaos;
Omar, Rumana;
... Shah, Taimur T; + view all
(2023)
External validation of a risk model predicting failure of salvage focal ablation for prostate cancer.
BJU International
10.1111/bju.16102.
|
|
Maffei, D;
Giganti, F;
Moore, CM;
(2023)
Seminar: Revisiting the value of PSA-based prostate cancer screening Essay No 5: Should men undergo MRI before prostate biopsy? (Pro).
Urologic Oncology: Seminars and Original Investigations
, 41
(2)
pp. 88-91.
10.1016/j.urolonc.2022.04.016.
|
|
Moore, Caroline M;
Frangou, Elena;
McCartan, Neil;
Santaolalla, Aida;
Kopcke, Douglas;
Brembilla, Giorgio;
Hadley, Joanna;
... Emberton, Mark; + view all
(2023)
Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: a prospective cohort study.
BMJ Oncology
, 2
(1)
, Article e000057. 10.1136/bmjonc-2023-000057.
|
|
Moore, Caroline M;
King, Lauren E;
Withington, John;
Amin, Mahul B;
Andrews, Mark;
Briers, Erik;
Chen, Ronald C;
... MacLennan, Steven; + view all
(2023)
Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting.
European Urology Oncology
10.1016/j.euo.2023.01.003.
(In press).
|
|
Patki, S;
Aquilina, J;
Thorne, R;
Aristidou, I;
Rodrigues, FB;
Warren, H;
Bex, A;
... Tran, MGB; + view all
(2023)
A Systematic Review of Patient Race, Ethnicity, Socioeconomic Status, and Educational Attainment in Prostate Cancer Treatment Randomised Trials—Is the Evidence Base Applicable to the General Patient Population?
European Urology Open Science
, 54
pp. 56-64.
10.1016/j.euros.2023.05.015.
(In press).
|
|
Reddy, Deepika;
van Son, Marieke;
Peters, Max;
Bertoncelli Tanaka, Mariana;
Dudderidge, Tim;
Cullen, Emma;
Ho, Carmen Lok Tung;
... Ahmed, Hashim U; + view all
(2023)
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.
Journal of Medical Economics
, 26
(1)
pp. 1099-1107.
10.1080/13696998.2023.2251849.
|
|
Woernle, A;
Dickinson, L;
Lelie, S;
Pendse, D;
Heffernan Ho, D;
Ramachandran, N;
Kirkham, A;
... Giganti, F; + view all
(2023)
A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centre.
European Journal of Radiology
, 162
, Article 110796. 10.1016/j.ejrad.2023.110796.
|
2022
|
Brembilla, G;
Giganti, F;
Sidhu, H;
Imbriaco, M;
Mallett, S;
Stabile, A;
Freeman, A;
... Punwani, S; + view all
(2022)
Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study.
Diagnostics
, 12
(2)
, Article 231. 10.3390/diagnostics12020231.
|
|
|
Dinneen, Eoin;
Shaw, Gregory L;
Kealy, Roseann;
Alexandris, Panos;
Finnegan, Kier;
Chu, Kimberley;
Haidar, Nadia;
... Chu, Kimberly; + view all
(2022)
Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing.
BJUI Compass
10.1002/bco2.169.
(In press).
|
|
Giganti, F;
Stavrinides, V;
Moore, CM;
(2022)
Magnetic Resonance Imaging–guided Active Surveillance of Prostate Cancer: Time to Say Goodbye to Protocol-based Biopsies.
European Urology Open Science
, 38
pp. 40-43.
10.1016/j.euros.2021.08.016.
|
|
|
Kasivisvanathan, V;
Chan, VWS;
Clement, KD;
Levis, B;
Haider, M;
Agarwal, R;
Emberton, M;
... Moore, CM; + view all
(2022)
A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancer.
PLoS ONE
, 17
, Article e0263345. 10.1371/journal.pone.0263345.
|
|
|
Kasivisvanathan, V;
Emberton, M;
Moore, CM;
(2022)
There Is No Longer a Role for Systematic Biopsies in Prostate Cancer Diagnosis.
European Urology Open Science
, 38
pp. 12-13.
10.1016/j.euros.2022.01.006.
|
|
|
Reddy, D;
Peters, M;
Shah, TT;
van Son, M;
Tanaka, MB;
Huber, PM;
Lomas, D;
... Ahmed, HU; + view all
(2022)
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.
European Urology
, 81
(4)
pp. 407-413.
10.1016/j.eururo.2022.01.005.
|
|
Remmers, Sebastiaan;
Helleman, Jozien;
Nieboer, Daan;
Trock, Bruce;
Hyndman, Matthew E;
Moore, Caroline M;
Gnanapragasam, Vincent;
... Roobol, Monique J; + view all
(2022)
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative.
European Urology Open Science
, 41
pp. 126-133.
10.1016/j.euros.2022.05.012.
|
|
Sampurno, Fanny;
Kowalski, Christoph;
Connor, Sarah E;
Nguyen, Anissa;
Acuna, Angels Pont;
Ng, Chi-Fai;
Foster, Claire;
... Papa, Nathan; + view all
(2022)
Knowledge and insights from a maturing international clinical quality registry.
Journal of the American Medical Informatics Association
, 29
(5)
pp. 964-969.
10.1093/jamia/ocab281.
|
|
Shah, Taimur T;
Kanthabalan, Abi;
Otieno, Marjorie;
Pavlou, Menelaos;
Omar, Rumana;
Adeleke, Sola;
Giganti, Francesco;
... Ahmed, Hashim U; + view all
(2022)
Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial.
European Urology
, 81
(6)
pp. 598-605.
10.1016/j.eururo.2022.02.022.
|
|
Singh, Saurabh;
Mathew, Manju;
Mertzanidou, Thomy;
Suman, Shipra;
Clemente, Joey;
Retter, Adam;
Papoutsaki, Marianthi-Vasiliki;
... Punwani, Shonit; + view all
(2022)
Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancer.
BMJ Open
, 12
(4)
, Article e059847. 10.1136/bmjopen-2021-059847.
|
|
|
Singh, Saurabh;
Rogers, Harriet;
Kanber, Baris;
Clemente, Joey;
Pye, Hayley;
Johnston, Edward W;
Parry, Tom;
... Punwani, Shonit; + view all
(2022)
Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study.
Radiology
, 305
(3)
pp. 623-630.
10.1148/radiol.212536.
|
|
Withington, J;
Moore, CM;
(2022)
Active Surveillance for Prostate Cancer: Will Magnetic Resonance Imaging Help Us Address the Current Controversies in Traditional Surveillance Approaches?
European Urology
, 81
(4)
pp. 347-348.
10.1016/j.eururo.2022.01.006.
|
2021
|
Abrams-Pompe, RS;
Fanti, S;
Schoots, IG;
Moore, CM;
Turkbey, B;
Vickers, AJ;
Walz, J;
... Eastham, JA; + view all
(2021)
The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature.
European Urology Oncology
, 4
(3)
pp. 370-395.
10.1016/j.euo.2020.11.002.
|
|
Cathcart, P;
Ribeiro, L;
Moore, C;
Ahmed, HU;
Leslie, T;
Arya, M;
Orczyk, C;
... Emberton, M; + view all
(2021)
Outcomes of the RAFT Trial: Robotic surgery After Focal Therapy.
BJU International
, 128
(4)
pp. 504-510.
10.1111/bju.15432.
|
|
Chang, SD;
Ghai, S;
Kim, CK;
Oto, A;
Giganti, F;
Moore, CM;
(2021)
MRI-Targeted Prostate Biopsy Techniques: AJR Expert Panel Narrative Review.
American Journal of Roentgenology
10.2214/AJR.21.26154.
(In press).
|
|
Feuer, Z;
Meng, X;
Rosenkrantz, AB;
Kasivisvanathan, V;
Moore, CM;
Huang, R;
Deng, F-M;
... Taneja, SS; + view all
(2021)
Application of the PRECISION Trial Biopsy Strategy to a Contemporary MRI-Targeted Biopsy Cohort: How Many Clinically Significant Prostate Cancers are Missed?
The Journal of Urology
, 205
pp. 740-747.
10.1097/JU.0000000000001406.
|
|
Giganti, F;
Lindner, S;
Piper, JW;
Kasivisvanathan, V;
Emberton, M;
Moore, CM;
Allen, C;
(2021)
Multiparametric prostate MRI quality assessment using a semi-automated PI-QUAL software program.
European Radiology Experimental
, 5
(1)
, Article 48. 10.1186/s41747-021-00245-x.
|
|
|
Giganti, F;
Allen, C;
Sridhar, A;
Tandogdu, Z;
Ramachandran, N;
Dickinson, L;
Haider, A;
... Moore, CM; + view all
(2021)
Mixed acinar and macrocystic ductal prostatic adenocarcinoma.
The Lancet Oncology
, 22
(1)
, Article e37. 10.1016/S1470-2045(20)30435-6.
|
|
Giganti, F;
Allen, C;
Stavrinides, V;
Stabile, A;
Haider, A;
Freeman, A;
Pashayan, N;
... Kirkham, A; + view all
(2021)
Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?
British Journal of Radiology
10.1259/bjr.20210321.
(In press).
|
|
|
Giganti, F;
Dinneen, E;
Kasivisvanathan, V;
Haider, A;
Freeman, A;
Kirkham, A;
Punwani, S;
... Allen, C; + view all
(2021)
Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.
European Radiology
10.1007/s00330-021-08169-1.
(In press).
|
|
|
Giganti, F;
Kasivisvanathan, V;
Kirkham, A;
Punwani, S;
Emberton, M;
Moore, CM;
Allen, C;
(2021)
Prostate MRI quality: a critical review of the last 5 years and the role of the PI-QUAL score.
The British Journal of Radiology
, 94
, Article 20210415. 10.1259/bjr.20210415.
|
|
|
Giganti, F;
Kirkham, A;
Kasivisvanathan, V;
Papoutsaki, M-V;
Punwani, S;
Emberton, M;
Moore, CM;
(2021)
Understanding PI-QUAL for prostate MRI quality: a practical primer for radiologists.
Insights into Imaging
, 12
, Article 59. 10.1186/s13244-021-00996-6.
|
|
|
Green, S;
Tuck, S;
Long, J;
Green, T;
Green, A;
Ellis, P;
Haire, A;
... Van Hemelrijck, M; + view all
(2021)
ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement.
Research Involvement and Engagement
, 7
(1)
, Article 81. 10.1186/s40900-021-00322-w.
|
|
|
Klotz, L;
Chin, J;
Black, PC;
Finelli, A;
Anidjar, M;
Bladou, F;
Machado, A;
... Haider, MA; + view all
(2021)
Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer A Phase 3 Randomized Clinical Trial.
JAMA Oncology
, 7
(4)
pp. 534-542.
10.1001/jamaoncol.2020.7589.
|
|
Marsden, T;
Lomas, DJ;
McCartan, N;
Hadley, J;
Tuck, S;
Brown, L;
Haire, A;
... ReIMAGINE Study Group; + view all
(2021)
ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI.
BMJ Open
, 11
(9)
, Article e048144. 10.1136/bmjopen-2020-048144.
|
|
|
Marsden, T;
McCartan, N;
Hadley, J;
Tuck, S;
Brown, L;
Haire, AJ;
Moss, CL;
... ReIMAGINE Study Group; + view all
(2021)
Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging.
European Urology Focus
, 7
(3)
pp. 503-505.
10.1016/j.euf.2021.03.027.
|
|
Merriel, SWD;
Moon, D;
Dundee, P;
Corcoran, N;
Carroll, P;
Partin, A;
Smith, JA;
... Costello, T; + view all
(2021)
A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance.
BMC Urology
, 21
, Article 18. 10.1186/s12894-021-00789-5.
|
|
|
Moore, CM;
(2021)
An important step towards smarter screening for prostate cancer.
Lancet Oncology
, 22
(9)
pp. 1201-1202.
10.1016/S1470-2045(21)00449-6.
|
|
Moore, CM;
Cole, AP;
Allen, C;
Giganti, F;
(2021)
Let's Follow the Golden Mean: Using Magnetic Resonance Imaging to Determine the Need for Biopsy in Men on Active Surveillance.
European Urology Oncology
, 4
(2)
pp. 235-236.
10.1016/j.euo.2020.11.009.
|
|
Norris, JM;
Simpson, BS;
Ball, R;
Freeman, A;
Kirkham, A;
Parry, MA;
Moore, CM;
... Emberton, M; + view all
(2021)
A Modified Newcastle-Ottawa Scale for Assessment of Study Quality in Genetic Urological Research.
European Urology
, 79
(3)
pp. 325-326.
10.1016/j.eururo.2020.12.017.
|
|
Norris, JM;
Simmons, LAM;
Kanthabalan, A;
Freeman, A;
McCartan, N;
Moore, CM;
Punwani, S;
... Ahmed, HU; + view all
(2021)
Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study.
European Urology Open Science
, 30
pp. 16-24.
10.1016/j.euros.2021.06.003.
|
|
|
Panebianco, Valeria;
Villeirs, Geert;
Weinreb, Jeffrey C;
Turkbey, Baris I;
Margolis, Daniel J;
Richenberg, Jonathan;
Schoots, Ivo G;
... Barentsz, Jelle O; + view all
(2021)
Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy.
European Urology Oncology
, 4
(6)
pp. 868-876.
10.1016/j.euo.2021.01.003.
|
|
Pye, H;
Singh, S;
Norris, JM;
Carmona Echeverria, LM;
Stavrinides, V;
Grey, A;
Dinneen, E;
... Whitaker, HC; + view all
(2021)
Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial.
Cancers
, 13
(8)
, Article 1985. 10.3390/cancers13081985.
|
|
|
Rakauskas, A;
Shah, TT;
Peters, M;
Randeva, JS;
Hosking-Jervis, F;
Schmainda, MJ;
Orczyck, C;
... Ahmed, HU; + view all
(2021)
Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?
Urologic Oncology: Seminars and Original Investigations
10.1016/j.urolonc.2021.04.017.
(In press).
|
|
|
Sampurno, F;
Cally, J;
Opie, JL;
Kannan, A;
Millar, JL;
Finelli, A;
Vickers, AJ;
... Evans, SM; + view all
(2021)
Establishing a global quality of care benchmark report.
Health Informatics Journal
, 27
(2)
, Article 14604582211015704. 10.1177/14604582211015704.
|
|
|
Sandhu, S;
Moore, CM;
Chiong, E;
Beltran, H;
Bristow, RG;
Williams, SG;
(2021)
Prostate cancer.
The Lancet
, 398
(10305)
pp. 1075-1090.
10.1016/S0140-6736(21)00950-8.
|
|
Santaolalla, A;
Hulsen, T;
Davis, J;
Ahmed, HU;
Moore, CM;
Punwani, S;
Attard, G;
... Van Hemelrijck, M; + view all
(2021)
The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer.
Frontiers in Artificial Intelligence
, 4
, Article 769582. 10.3389/frai.2021.769582.
|
|
|
Schoots, IG;
Barentsz, JO;
Bittencourt, LK;
Haider, MA;
Macura, KJ;
Margolis, DJA;
Moore, CM;
... Padhani, AR; + view all
(2021)
PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy-Naive Men With Suspected Prostate Cancer: Narrative Review.
American Journal of Roentgenology (AJR)
, 216
(1)
pp. 3-19.
10.2214/AJR.20.24268.
|
|
Shah, TT;
Reddy, D;
Peters, M;
Ball, D;
Kim, NH;
Gomez, EG;
Miah, S;
... Winkler, M; + view all
(2021)
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study.
Prostate Cancer and Prostatic Diseases
, 24
pp. 567-574.
10.1038/s41391-020-00315-y.
|
|
Singh, S;
Moore, CM;
Punwani, S;
Mitra, AV;
Bandula, S;
(2021)
Long-term biopsy outcomes in prostate cancer patients treated with external beam radiotherapy: a systematic review and meta-analysis.
Prostate Cancer and Prostatic Diseases
10.1038/s41391-021-00323-6.
(In press).
|
|
|
Stavrinides, V;
Giganti, F;
Allen, C;
Kirkham, A;
Punwani, S;
Freeman, A;
Norris, J;
... Emberton, M; + view all
(2021)
Follow-Up of Men With PI-RADS 4 or 5 Abnormality on Prostate MRI and Non-Malignant Pathologic Findings on Initial Targeted Prostate Biopsy.
[Letter].
The Journal of Urology
, 205
(5)
pp. 1526-1528.
10.1097/JU.0000000000001589.
|
|
Stavrinides, V;
Freeman, A;
Ball, R;
Haider, A;
Pashayan, N;
Moore, CM;
Emberton, M;
(2021)
Chronic Baseline Prostate Inflammation is Associated with Lower Tumor Grade in Men with Prostate Cancer on Repeat Biopsy: Results from the REDUCE Study. Letter.
Journal of Urology
, 205
(4)
pp. 1233-1234.
10.1097/JU.0000000000001587.
|
|
Stavrinides, V;
Papageorgiou, G;
Danks, D;
Giganti, F;
Pashayan, N;
Trock, B;
Freeman, A;
... Moore, CM; + view all
(2021)
Mapping PSA density to outcome of MRI-based active surveillance for prostate cancer through joint longitudinal-survival models.
Prostate Cancer and Prostatic Diseases
10.1038/s41391-021-00373-w.
(In press).
|
|
|
Stonier, T;
Simson, N;
Shah, T;
Lobo, N;
Amer, T;
Lee, S-M;
Bass, E;
... Ahmed, HU; + view all
(2021)
The “Is mpMRI Enough” or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with Biopsy.
European Urology Focus
, 7
(5)
pp. 1027-1034.
10.1016/j.euf.2020.09.012.
|
|
Tschirdewahn, S;
Wiesenfarth, M;
Bonekamp, D;
Püllen, L;
Reis, H;
Panic, A;
Kesch, C;
... Radtke, JP; + view all
(2021)
Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography-fusion Biopsy.
European Urology Focus
, 7
(6)
pp. 1300-1307.
10.1016/j.euf.2020.06.020.
|
|
van Son, MJ;
Peters, M;
Reddy, D;
Shah, TT;
Hosking-Jervis, F;
Robinson, S;
Lagendijk, JJW;
... Falconer, A; + view all
(2021)
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control.
Prostate Cancer and Prostatic Diseases
, 24
pp. 1120-1128.
10.1038/s41391-021-00369-6.
|
|
Wu, RC;
Lebastchi, AH;
Hadaschik, BA;
Emberton, M;
Moore, C;
Laguna, P;
Futterer, JJ;
(2021)
Role of MRI for the detection of prostate cancer.
World Journal of Urology
, 39
pp. 637-649.
10.1007/s00345-020-03530-3.
|
|
Yang, Q;
Vercauteren, T;
Fu, Y;
Giganti, F;
Ghavami, N;
Stavrinides, V;
Moore, CM;
... Hu, Y; + view all
(2021)
Morphological Change Forecasting for Prostate Glands using Feature-based Registration and Kernel Density Extrapolation.
In:
Proceedings of the International Symposium on Biomedical Imaging (IEEE ISBI 2021).
IEEE: Virtual conference.
(In press).
|
|
2020
|
Ahmed, HU;
Huber, P;
Afzal, N;
Arya, M;
Boxler, S;
Dudderidge, T;
Emberton, M;
... Winkler, M; + view all
(2020)
An Exploratory Study of Dose Escalation vs Standard Focal High-Intensity Focused Ultrasound for Treating Nonmetastatic Prostate Cancer.
Journal of Endourology
, 34
(6)
pp. 641-646.
10.1089/end.2019.0613.
|
|
Checcucci, E;
De Cillis, S;
Piramide, F;
Amparore, D;
Kasivisvanathan, V;
Giganti, F;
Fiori, C;
... Porpiglia, F; + view all
(2020)
The role of additional standard biopsy in the MRI-targeted biopsy era.
Minerva Urologica e Nefrologica
, 72
(5)
pp. 637-639.
10.23736/S0393-2249.20.03958-2.
|
|
Eldred-Evans, D;
Neves, JB;
Simmons, LAM;
Kanthabalan, A;
McCartan, N;
Shah, TT;
Arya, M;
... Ahmed, HU; + view all
(2020)
The added value of diffusion-weighted images and dynamic contrast-enhancement in multi-parametric MRI for the detection of clinically significant prostate cancer in the PICTURE trial.
BJU International
, 125
(3)
pp. 391-398.
10.1111/bju.14953.
|
|
Fiard, G;
Norris, JM;
Nguyen, TA;
Stavrinides, V;
Olivier, J;
Emberton, M;
Moore, CM;
(2020)
What to expect from a non-suspicious prostate MRI? A review = Que peut-on attendre d’une IRM prostatique non suspecte ? Une revue de la littérature.
Progrès en Urologie
, 30
(16)
pp. 986-999.
10.1016/j.purol.2020.09.012.
|
|
Giganti, F;
Stavrinides, V;
Stabile, A;
Osinibi, E;
Orczyk, C;
Radtke, JP;
Freeman, A;
... Moore, CM; + view all
(2020)
Prostate cancer measurements on serial MRI during active surveillance: it’s time to be PRECISE.
British Journal of Radiology
, 93
(1116)
, Article 20200819. 10.1259/bjr.20200819.
|
|
Giganti, F;
Allen, C;
Emberton, M;
Moore, CM;
Kasivisvanathan, V;
PRECISION study group, .;
(2020)
Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial.
European Urology Oncology
, 3
(5)
pp. 615-619.
10.1016/j.euo.2020.06.007.
|
|
Giganti, F;
Kirkham, A;
Allen, C;
Punwani, S;
Orczyk, C;
Emberton, M;
Moore, CM;
(2020)
Update on multiparametric prostate MRI during active surveillance: current and future trends and role of the PRECISE recommendations.
American Journal of Roentgenology
10.2214/AJR.20.23985.
(In press).
|
|
Giganti, F;
Pecoraro, M;
Fierro, D;
Campa, R;
Del Giudice, F;
Punwani, S;
Kirkham, A;
... Panebianco, V; + view all
(2020)
DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations.
Magnetic Resonance Imaging
, 67
pp. 50-58.
10.1016/j.mri.2019.12.007.
|
|
Giganti, F;
Stabile, A;
Stavrinides, V;
Osinibi, E;
Retter, A;
Orczyk, C;
Panebianco, V;
... Moore, CM; + view all
(2020)
Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort.
European Radiology
10.1007/s00330-020-07256-z.
(In press).
|
|
|
Grummet, J;
Gorin, MA;
Popert, R;
O'Brien, T;
Lamb, AD;
Hadaschik, B;
Radtke, JP;
... Woo, HH; + view all
(2020)
“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now.
Prostate Cancer and Prostatic Diseases
10.1038/s41391-020-0204-8.
(In press).
|
|
|
Huber, PM;
Afzal, N;
Arya, M;
Boxler, S;
Dudderidge, T;
Emberton, M;
Guillaumier, S;
... Ahmed, HU; + view all
(2020)
Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound.
The Journal of Urology
, 203
pp. 1-9.
10.1097/JU.0000000000000747.
|
|
Huber, PM;
Afzal, N;
Arya, M;
Boxler, S;
Dudderidge, T;
Emberton, M;
Guillaumier, S;
... Ahmed, HU; + view all
(2020)
Focal HIFU therapy for anterior compared to posterior prostate cancer lesions.
World Journal of Urology
10.1007/s00345-020-03297-7.
(In press).
|
|
|
Kasivisvanathan, V;
Lindsay, J;
Rakshani-Moghadam, S;
Elhamshary, A;
Kapriniotis, K;
Kazantzis, G;
Syed, B;
... UCLH study group collaborators; + view all
(2020)
A cohort study of 30 day mortality after NON-EMERGENCY surgery in a COVID-19 cold site.
International Journal of Surgery
, 84
pp. 57-65.
10.1016/j.ijsu.2020.10.019.
|
|
|
Lovegrove, CE;
Peters, M;
Guillaumier, S;
Arya, M;
Afzal, N;
Dudderidge, T;
Hosking-Jervis, F;
... Minhas, S; + view all
(2020)
Evaluation of functional outcomes after a second focal high‐intensity focused ultrasonography (HIFU) procedure in men with primary localized, non‐metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registry.
BJU International
, 125
(6)
pp. 853-860.
10.1111/bju.15004.
|
|
Protopapa, E;
Van der Meulen, J;
Moore, CM;
Smith, SC;
(2020)
Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis.
BMJ Open
, 10
(11)
, Article e035436. 10.1136/bmjopen-2019-035436.
|
|
|
Sathianathen, NJ;
Omer, A;
Harriss, E;
Davies, L;
Kasivisvanathan, V;
Punwani, S;
Moore, CM;
... Lamb, AD; + view all
(2020)
Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.
European Urology
, 78
(3)
pp. 402-414.
10.1016/j.eururo.2020.03.048.
|
|
Simpson, BS;
Camacho, N;
Luxton, HJ;
Pye, H;
Finn, R;
Heavey, S;
Pitt, J;
... Whitaker, HC; + view all
(2020)
Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.
Communications Biology
, 3
(1)
, Article 440. 10.1038/s42003-020-01175-x.
|
|
|
Stabile, A;
Giganti, F;
Kasivisvanathan, V;
Giannarini, G;
Moore, CM;
Padhani, AR;
Panebianco, V;
... Barentsz, JO; + view all
(2020)
Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.
European Urology Oncology
, 3
(2)
pp. 145-167.
10.1016/j.euo.2020.02.005.
|
|
Stabile, A;
Giganti, F;
Rosenkrantz, AB;
Taneja, SS;
Villeirs, G;
Gill, IS;
Allen, C;
... Kasivisvanathan, V; + view all
(2020)
Multiparametric MRI for prostate cancer diagnosis: current status and future directions.
Nature Reviews Urology
, 17
pp. 41-61.
10.1038/s41585-019-0212-4.
|
|
Stabile, A;
Orczyk, C;
Giganti, F;
Moschini, M;
Allen, C;
Punwani, S;
Cathala, N;
... Moore, CM; + view all
(2020)
The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series.
European Urology
, 78
(2)
pp. 155-160.
10.1016/j.eururo.2020.04.068.
|
|
Stavrinides, V;
Dalgleish, A;
Copier, JP;
Moore, CM;
(2020)
Mycobacterial immunotherapy for prostate cancer: where can we go from here?
Nature Reviews Urology
, 17
pp. 189-190.
10.1038/s41585-020-0283-2.
|
|
Stavrinides, V;
Giganti, F;
Emberton, M;
Moore, CM;
(2020)
Reply to Francesco Montorsi, Giorgio Gandaglia, Nicola Fossati, Andrea Salonia, and Alberto Briganti’s Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443–51.
European Urology
, 78
(4)
e166.
10.1016/j.eururo.2020.07.010.
|
|
Stavrinides, V;
Giganti, F;
Emberton, M;
Moore, CM;
(2020)
Reply to Carissa E. Chu, Peter E. Lonergan, and Peter R. Carroll’s Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443–51.
European Urology
, 78
(3)
e112-e113.
10.1016/j.eururo.2020.06.038.
|
|
Stavrinides, V;
Giganti, F;
Punwani, S;
Allen, C;
Kirkham, A;
Freeman, A;
Ball, R;
... Moore, CM; + view all
(2020)
Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?
The Journal Of Urology
, 24
(5)
pp. 1065-1066.
10.1097/JU.0000000000001295.
|
|
Stavrinides, V;
Giganti, F;
Trock, B;
Punwani, S;
Allen, C;
Kirkham, A;
Freeman, A;
... Moore, CM; + view all
(2020)
Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study.
European Urology
10.1016/j.eururo.2020.03.035.
(In press).
|
|
|
Vindrola-Padros, C;
Ramsay, AI;
Perry, C;
Darley, S;
Wood, VJ;
Clarke, CS;
Hines, J;
... Fulop, NJ; + view all
(2020)
Implementing major system change in specialist cancer surgery: The role of provider networks.
Journal of Health Services Research & Policy
10.1177/1355819620926553.
(In press).
|
|
2019
|
Dieffenbacher, S;
Nyarangi-Dix, J;
Giganti, F;
Bonekamp, D;
Kesch, C;
Müller-Wolf, MB;
Schütz, V;
... Radtke, JP; + view all
(2019)
Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance.
European Urology Focus
10.1016/j.euf.2019.03.001.
(In press).
|
|
Ghavami, N;
Hu, Y;
Gibson, E;
Bonmati, E;
Emberton, M;
Moore, CM;
Barratt, DC;
(2019)
Automatic segmentation of prostate MRI using convolutional neural networks: Investigating the impact of network architecture on the accuracy of volume measurement and MRI-ultrasound registration.
Medical Image Analysis
, 58
, Article 101558. 10.1016/j.media.2019.101558.
|
|
|
Giganti, F;
Allen, C;
Piper, JW;
Mirando, D;
Stabile, A;
Punwani, S;
Kirkham, A;
... Moore, CM; + view all
(2019)
Sequential prostate MRI reporting in men on active surveillance: initial experience of a dedicated PRECISE software program.
Magnetic Resonance Imaging
, 57
pp. 34-39.
10.1016/j.mri.2018.10.013.
|
|
Giganti, F;
Moore, CM;
(2019)
MRI in early detection of prostate cancer.
Current Opinion in Urology
, 29
(6)
pp. 563-568.
10.1097/MOU.0000000000000668.
|
|
Giganti, F;
Pecoraro, M;
Stavrinides, V;
Stabile, A;
Cipollari, S;
Sciarra, A;
Kirkham, A;
... Panebianco, V; + view all
(2019)
Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study.
European Radiology
10.1007/s00330-019-06557-2.
(In press).
|
|
|
Giganti, F;
Rosenkrantz, AB;
Villeirs, G;
Panebianco, V;
Stabile, A;
Emberton, M;
Moore, CM;
(2019)
The Evolution of MRI of the Prostate: The Past, the Present, and the Future.
American Journal of Roentgenology
10.2214/AJR.18.20796.
(In press).
|
|
Giganti, F;
Stabile, A;
Giona, S;
Marenco, J;
Orczyk, C;
Moore, CM;
Allen, C;
... Punwani, S; + view all
(2019)
Prostate cancer treated with irreversible electroporation: MRI-based volumetric analysis and oncological outcome.
Magnetic Resonance Imaging
, 58
pp. 143-147.
10.1016/j.mri.2019.02.003.
|
|
Giganti, F;
Stabile, A;
Moore, CM;
(2019)
Resonancia magnética y cáncer de próstata: perspectivas desde Reino Unido, Europa y Estados Unidos = Magnetic resonance imaging and prostate cancer: perspectives from the UK, Europe and USA.
Archivos españoles de urología
, 72
(2)
pp. 135-141.
|
|
Hamid, S;
Donaldson, IA;
Hu, Y;
Rodell, R;
Villarini, B;
Bonmati, E;
Tranter, P;
... Ahmed, HU; + view all
(2019)
The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification.
European Urology
, 75
(5)
pp. 733-740.
10.1016/j.eururo.2018.08.007.
|
|
|
Johnston, EW;
Bonet-Carne, E;
Ferizi, U;
Yvernault, B;
Pye, H;
Patel, D;
Clemente, J;
... Punwani, S; + view all
(2019)
VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.
Radiology
, 291
(2)
pp. 391-397.
10.1148/radiol.2019181749.
|
|
Johnston, EW;
Latifoltojar, A;
Sidhu, H;
Ramachandran, N;
Sokolska, M;
Bainbridge, A;
Moore, C;
... Punwani, S; + view all
(2019)
Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
European Radiology
, 29
pp. 3159-3169.
10.1007/s00330-018-5813-4.
|
|
|
Kasivisvanathan, V;
Ambrosi, A;
Giganti, F;
Chau, E;
Kirkham, A;
Punwani, S;
Allen, C;
... Moore, CM; + view all
(2019)
A Dedicated Prostate MRI Teaching Course Improves the Ability of the Urologist to Interpret Clinically Significant Prostate Cancer on Multiparametric MRI.
European Urology
, 75
(1)
pp. 203-204.
10.1016/j.eururo.2018.09.033.
|
|
Kasivisvanathan, Veerappan;
(2019)
The role of MRI-targeted biopsy in the diagnosis of prostate cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Marconi, L;
Stonier, T;
Tourinho-Barbosa, R;
Moore, C;
Ahmed, HU;
Cathelineau, X;
Emberton, M;
... Cathcart, P; + view all
(2019)
Robot-assisted Radical Prostatectomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence.
European Urology
, 76
(1)
pp. 27-30.
10.1016/j.eururo.2019.03.007.
|
|
Marenco, J;
Orczyk, C;
Collins, T;
Moore, C;
Emberton, M;
(2019)
Role of MRI in planning radical prostatectomy: what is the added value?
World Journal of Urology
, 37
pp. 1289-1292.
10.1007/s00345-019-02762-2.
|
|
Merriel, SWD;
Hetherington, L;
Seggie, A;
Castle, JT;
Cross, W;
Roobol, MJ;
Gnanapragasam, V;
... Prostate Cancer UK Expert Reference Group on Active Surveillance; + view all
(2019)
Best practice in Active Surveillance for men with prostate cancer: A Prostate Cancer UK consensus statement.
BJU International
, 124
pp. 47-54.
10.1111/bju.14707.
|
|
|
Radtke, JP;
Giganti, F;
Wiesenfarth, M;
Stabile, A;
Marenco, J;
Orczyk, C;
Kasivisvanathan, V;
... Moore, CM; + view all
(2019)
Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS.
PLoS One
, 14
(8)
, Article e0221350. 10.1371/journal.pone.0221350.
|
|
|
Stabile, A;
Orczyk, C;
Hosking-Jervis, F;
Giganti, F;
Arya, M;
Hindley, RG;
Dickinson, L;
... Moore, CM; + view all
(2019)
Medium term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using HIFU for primary localized prostate cancer.
BJU International
, 124
(3)
pp. 431-440.
10.1111/bju.14710.
|
|
Stavrinides, V;
Giganti, F;
Emberton, M;
Moore, CM;
(2019)
MRI in active surveillance: a critical review.
Prostate Cancer and Prostatic Diseases
, 22
pp. 5-15.
10.1038/s41391-018-0077-2.
|
2018
|
Bass, EJ;
Freeman, A;
Jameson, C;
Punwani, S;
Moore, CM;
Arya, M;
Emberton, M;
(2018)
Prostate Cancer Diagnostic Pathway: Is a One-stop Cognitive Mri Targeted Biopsy Service a Realistic Goal in Everyday Practice? A Pilot Cohort in a Tertiary Referral Centre in the UK.
BMJ Open
, 8
(10)
, Article e024941. 10.1136/bmjopen-2018-024941.
|
|
|
Bonmati, E;
Hu, Y;
Villarini, B;
Rodell, R;
Martin, P;
Han, L;
Donaldson, I;
... Barratt, DC; + view all
(2018)
Technical Note: Error metrics for estimating the accuracy of needle/instrument placement during transperineal MR/US-guided prostate interventions.
Medical Physics
10.1002/mp.12814.
(In press).
|
|
Brizmohun, M;
Johnston, E;
Latifoltojar, A;
O'Callaghan, J;
Bonet-Carne, E;
Ferizi, U;
Yvernault, B;
... Punwani, S; + view all
(2018)
The intracellular component of VERDICT (Vascular, Extracellular, and Restricted Diffusion for Cytometry in Tumors) MRI distinguishes Gleason 4 pattern better than Apparent Diffusion Coefficient.
Presented at: Joint Annual Meeting ISMRM-ESMRMB 2018, Paris Expo Porte de Versailles, Paris, France.
|
|
Brizmohun Appayya, M;
Adshead, J;
Ahmed, HU;
Allen, C;
Bainbridge, A;
Barrett, T;
Giganti, F;
... Punwani, S; + view all
(2018)
National implementation of multi‐parametric magnetic resonance imaging for prostate cancer detection – recommendations from a UK consensus meeting.
BJU International
, 122
(1)
pp. 13-25.
10.1111/bju.14361.
|
|
|
Bruinsma, SM;
Zhang, L;
Roobol, MJ;
Bangma, CH;
Steyerberg, EW;
Nieboer, D;
Van Hemelrijck, M;
... Buzza, M; + view all
(2018)
The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date.
BJU International
, 121
(5)
pp. 737-744.
10.1111/bju.14106.
|
|
Faure Walker, NA;
Norris, JM;
Shah, TT;
Yap, T;
Cathcart, P;
Moore, CM;
Ahmed, HU;
... Minhas, S; + view all
(2018)
A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic review.
Urologic Oncology: Seminars and Original Investigations
, 36
(2)
pp. 67-76.
10.1016/j.urolonc.2017.12.002.
|
|
Ghavami, N;
Hu, Y;
Bonmati, E;
Rodell, R;
Gibson, E;
Moore, C;
Barratt, D;
(2018)
Integration of spatial information in convolutional neural networks for automatic segmentation of intraoperative transrectal ultrasound images.
Journal of Medical Imaging
, 6
(1)
, Article 011003. 10.1117/1.JMI.6.1.011003.
|
|
|
Ghavami, N;
Hu, Y;
Bonmati, E;
Rodell, R;
Gibson, E;
Moore, CM;
Barratt, DC;
(2018)
Automatic slice segmentation of intraoperative transrectal ultrasound images using convolutional neural networks.
In: Fei, B and Webster, RJ, (eds.)
Proceedings Volume 10576, Medical Imaging 2018: Image-Guided Procedures, Robotic Interventions, and Modeling.
(pp. p. 1057603).
SPIE: Houston, Texas, United States.
|
|
|
Gibson, E;
Hu, Y;
Ghavami, N;
Ahmed, HU;
Moore, C;
Emberton, M;
Huisman, HJ;
(2018)
Inter-site Variability in Prostate Segmentation Accuracy Using Deep Learning.
In: Frangi, A and Schnabel, J and Davatzikos, C and Alberola-López, C and Fichtinger, G, (eds.)
Medical Image Computing and Computer Assisted Intervention – MICCAI 2018. MICCAI 2018. Lecture Notes in Computer Science.
(pp. pp. 506-514).
Springer: Cham, Switzerland.
|
|
Giganti, F;
Gambarota, G;
Moore, CM;
McCartan, N;
Emberton, M;
Allen, C;
KIRKHAM, A;
(2018)
The effects of dutasteride on quantitative T2 and T2-weighted imaging in men on active surveillance for prostate cancer: results from a placebo-controlled, randomized clinical trial.
Presented at: Joint Annual Meeting ISMRM-ESMRMB 2018, Paris, France.
|
|
Giganti, F;
Gambarota, G;
Moore, CM;
Robertson, NL;
McCartan, N;
Jameson, C;
Bott, SRJ;
... Kirkham, A; + view all
(2018)
Prostate cancer detection using quantitative T2 and T2‐weighted imaging: The effects of 5‐alpha‐reductase inhibitors in men on active surveillance.
Journal of Magnetic Resonance Imaging
, 47
(6)
pp. 1646-1653.
10.1002/jmri.25891.
|
|
Giganti, F;
Moore, CM;
(2018)
Magnetic resonance imaging in active surveillance-a modern approach.
[Review].
Translational Andrology and Urology
, 7
(1)
pp. 116-131.
10.21037/tau.2017.12.23.
|
|
Guillaumier, S;
Peters, M;
Arya, M;
Afzal, N;
Charman, S;
Dudderidge, T;
Hosking-Jervis, F;
... Ahmed, HU; + view all
(2018)
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.
European Urology
, 74
(4)
pp. 422-429.
10.1016/j.eururo.2018.06.006.
|
|
|
Hu, Y;
Gibson, E;
Ghavami, N;
Bonmati, E;
Moore, CM;
Emberton, M;
Vercauteren, T;
... Barratt, DC; + view all
(2018)
Adversarial deformation regularization for training image registration neural networks.
In: Frangi, AF and Schnabel, JA and Davatzikos, C and Alberola-López, C and Fichtinger, G, (eds.)
Medical Image Computing and Computer Assisted Intervention – MICCAI 2018: 21st International Conference, Granada, Spain, September 16-20, 2018, Proceedings, Part I.
(pp. pp. 774-782).
Springer: Cham, Switzerland.
|
|
Hu, Y;
Modat, M;
Gibson, E;
Ghavami, N;
Bonmati, E;
Moore, CM;
Emberton, M;
... Vercauteren, T; + view all
(2018)
Label-driven weakly-supervised learning for multimodal deformable image registration.
In:
2018 IEEE 15th International Symposium on Biomedical Imaging.
(pp. pp. 1070-1074).
IEEE
|
|
|
Hu, Y;
Modat, M;
Gibson, E;
Li, W;
Ghavami, N;
Bonmati, E;
Wang, G;
... Vercauteren, T; + view all
(2018)
Weakly-supervised convolutional neural networks for multimodal image registration.
Medical Image Analysis
, 49
pp. 1-13.
10.1016/j.media.2018.07.002.
|
|
|
Kasivisvanathan, V;
Emberton, M;
Moore, CM;
(2018)
"Don't Let the Perfect Be the Enemy of the Good": Time to Embrace Magnetic Resonance Imaging Before First Prostate Biopsy.
[Editorial comment].
European Urology
, 74
(4)
pp. 411-412.
10.1016/j.eururo.2018.06.012.
|
|
Kasivisvanathan, V;
Emberton, M;
Moore, CM;
(2018)
MRI-Targeted Biopsy for Prostate-Cancer Diagnosis: The authors reply.
The New England Journal of Medicine
, 379
(6)
pp. 589-590.
10.1056/NEJMc1807507.
|
|
Kasivisvanathan, V;
Rannikko, AS;
Borghi, M;
Panebianco, V;
Mynderse, LA;
Vaarala, MH;
Briganti, A;
... PRECISION Study Group Collaborators; + view all
(2018)
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
The New England Journal of Medicine
10.1056/NEJMoa1801993.
(In press).
|
|
Melnychuk, M;
Vindrola, C;
Aitchison, M;
CLARKE, C;
Fulop, N;
Levermore, C;
Madinneni, S;
... Morris, S; + view all
(2018)
Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionals.
BMC Cancer
, 18
, Article 226. 10.1186/s12885-018-4137-8.
|
|
|
Miah, S;
Eldred-Evans, D;
Simmons, LAM;
Shah, TT;
Kanthabalan, A;
Arya, M;
Winkler, M;
... Ahmed, HU; + view all
(2018)
Patient Reported Outcome Measures for Transperineal Template Prostate Mapping Biopsies in the PICTURE Study.
The Journal of Urology
, 200
(6)
pp. 1235-1240.
10.1016/j.juro.2018.06.033.
|
|
Moore, C;
(2018)
Can Negative Prostate Magnetic Resonance Imaging Give Us the Reassurance We Need To Avoid Standard Biopsy? An Evidence-based Practical Approach.
[Editorial comment].
European Urology
, 74
(1)
pp. 55-56.
10.1016/j.eururo.2018.03.042.
|
|
Olivier, J;
Stavrinides, V;
Kay, J;
Freeman, A;
Pye, H;
Ahmed, Z;
Carmona Echeverria, L;
... Whitaker, HC; + view all
(2018)
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI‐characterized prostates.
The Prostate
, 78
(16)
pp. 1229-1237.
10.1002/pros.23698.
|
|
Peters, M;
Kanthabalan, A;
Shah, TT;
McCartan, N;
Moore, CM;
Arya, M;
Van der Voort van Zyp, JR;
... Ahmed, HU; + view all
(2018)
Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses.
Urologic Oncology
, 36
(1)
13.e1-13.e10.
10.1016/j.urolonc.2017.08.022.
|
|
Protopapa, E;
Smith, SC;
Brew-Graves, C;
Miah, H;
Hamer, K;
Shah, N;
Koupparis, A;
... Moore, CM; + view all
(2018)
Truenth Uk Post Surgery - Urinary Function In The 1st Post-operative Year In A 1000 Man Contemporary Radical Prostatectomy Cohort.
Presented at: American-Urological-Association (AUA) Annual Meeting 2018, San Francisco, California, USA.
|
|
Sampurno, F;
Zheng, J;
Di Stefano, L;
Millar, JL;
Foster, C;
Fuedea, F;
Higano, C;
... Evans, S; + view all
(2018)
Quality Indicators for Global Benchmarking of Localized Prostate Cancer Management.
The Journal of Urology
, 200
(2)
pp. 319-326.
10.1016/j.juro.2018.02.071.
|
|
Schoots, IG;
Nieboer, D;
Giganti, F;
Moore, CM;
Bangma, CH;
Roobol, MJ;
(2018)
Is magnetic resonance imaging‐targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low‐risk prostate cancer? A systematic review and meta‐analysis.
BJU International
, 122
(6)
pp. 946-958.
10.1111/bju.14358.
|
|
|
Simmons, LAM;
Kanthabalan, A;
Arya, M;
Briggs, T;
Barratt, D;
Charman, SC;
Freeman, A;
... Ahmed, HU; + view all
(2018)
Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial.
The Journal of Urology
, 200
(6)
pp. 1227-1234.
10.1016/j.juro.2018.07.001.
|
|
Simmons, LAM;
Kanthabalan, A;
Arya, M;
Briggs, T;
Charman, SC;
Freeman, A;
Gelister, J;
... Ahmed, HU; + view all
(2018)
Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning.
Prostate Cancer and Prostatic Diseases
10.1038/s41391-018-0094-1.
|
|
Stabile, A;
Giganti, F;
Emberton, M;
Moore, CM;
(2018)
MRI in prostate cancer diagnosis: do we need to add standard sampling? A review of the last 5 years.
[Review].
Prostate Cancer and Prostatic Diseases
, 21
pp. 473-487.
10.1038/s41391-018-0071-8.
|
|
Stavrinides, V;
Giganti, F;
Stabile, A;
Allen, C;
Punwani, S;
Whitaker, HC;
Emberton, M;
(2018)
Baseline characteristics in an MRI-based active surveillance cohort: Association with clinical and histological outcomes.
Presented at: EAU 18: 33rd Annual European Association of Urology Congress, Copenhagen.
|
2017
|
Bass, EJ;
Donaldson, IA;
Freeman, A;
Jameson, C;
Punwani, S;
Moore, C;
Arya, M;
... Ahmed, HU; + view all
(2017)
Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach.
Prostate Cancer and Prostatic Diseases
, 20
pp. 311-317.
10.1038/pcan.2017.13.
|
|
Bruinsma, SM;
Roobol, MJ;
Carroll, PR;
Klotz, L;
Pickles, T;
Moore, CM;
Gnanapragasam, VJ;
... Movember Foundation's Global Action Plan Prostate Cancer, Active; + view all
(2017)
Expert consensus document: Semantics in active surveillance for men with localized prostate cancer — results of a modified Delphi consensus procedure.
Nature Reviews Urology
, 14
pp. 312-322.
10.1038/nrurol.2017.26.
|
|
|
Evans, SM;
Millar, JL;
Moore, CM;
Lewis, JD;
Huland, H;
Sampurno, F;
Connor, SE;
... Litwin, MS; + view all
(2017)
Cohort profile: the TrueNTH Global Registry - an international registry to monitor and improve localised prostate cancer health outcomes.
BMJ Open
, 7
(11)
, Article e017006. 10.1136/bmjopen-2017-017006.
|
|
|
Giganti, F;
Moore, CM;
(2017)
A critical comparison of techniques for MRI-targeted biopsy of the prostate.
Translational Andrology and Urology
, 6
(3)
pp. 432-443.
10.21037/tau.2017.03.77.
|
|
|
Giganti, F;
Moore, CM;
Robertson, NL;
McCartan, N;
Jameson, C;
Bott, SRJ;
Winkler, M;
... Kirkham, A; + view all
(2017)
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial.
EUROPEAN RADIOLOGY
, 27
(11)
pp. 4767-4774.
10.1007/s00330-017-4858-0.
|
|
Hu, Y;
Gibson, E;
Vercauteren, T;
Ahmed, H;
Emberton, M;
Moore, C;
Noble, JA;
(2017)
Intraoperative Organ Motion Models with an Ensemble of Conditional Generative Adversarial Networks.
In: Descoteaux, M and Maier-Hein, L and Franz, A and Jannin, P and Collins, DL and Duchesne, S, (eds.)
Medical Image Computing and Computer-Assisted Intervention − MICCAI 2017: 20th International Conference, Quebec City, QC, Canada, September 11-13, 2017, Proceedings, Part II.
(pp. pp. 368-376).
Springer International Publishing: Cham, Switzerland.
|
|
|
Hu, Y;
Kasivisvanathan, V;
Simmons, L;
Clarkson, M;
Thompson, S;
Shah, T;
Ahmed, H;
... Barratt, D; + view all
(2017)
Development and Phantom Validation of a 3D-Ultrasound-Guided System for Targeting MRI-visible Lesions during Transrectal Prostate Biopsy.
IEEE Transactions on Biomedical Engineering
, 64
(4)
pp. 946-958.
10.1109/TBME.2016.2582734.
|
|
Kanthabalan, A;
Peters, M;
Van Vulpen, M;
McCartan, N;
Hindley, RG;
Emara, A;
Moore, MC;
... Ahmed, HU; + view all
(2017)
Focal Salvage HIFU in radiorecurrent prostate cancer.
BJU International
, 120
(2)
pp. 246-256.
10.1111/bju.13831.
|
|
Kasivisvanathan, V;
Jichi, F;
Klotz, L;
Villers, A;
Taneja, SS;
Punwani, S;
Freeman, A;
... Moore, CM; + view all
(2017)
A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol.
BMJ Open
, 7
(10)
, Article e017863. 10.1136/bmjopen-2017-017863.
|
|
|
Martinez de Pinillos Bayona, A;
Woodhams, JH;
Pye, H;
Hamoudi, RA;
Moore, CM;
MacRobert, AJ;
(2017)
Efficacy of photochemical internalisation using disulfonated chlorin and porphyrin photosensitisers: An in vitro study in 2D and 3D prostate cancer models.
Cancer Letters
, 393
pp. 68-75.
10.1016/j.canlet.2017.02.018.
|
|
Moore, CM;
Giganti, F;
Albertsen, P;
Allen, C;
Bangma, C;
Briganti, A;
Carroll, P;
... Schoots, I; + view all
(2017)
Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force.
European Urology
, 71
(4)
pp. 648-655.
10.1016/j.eururo.2016.06.011.
|
|
|
Moore, CM;
Robertson, NL;
Jichi, F;
Damola, A;
Ambler, G;
Giganti, F;
Ridout, AJ;
... Emberton, M; + view all
(2017)
The effect of dutasteride on MRI-defined prostate cancer lesions: MAPPED (Magnetic resonance imaging in Primary Prostate Cancer after Exposure to Dutasteride) - a randomized placebo-controlled, double-blind clinical trial.
The Journal of Urology
, 197
(4)
pp. 1006-1013.
10.1016/j.juro.2016.11.090.
|
|
Protopapa, E;
van der Meulen, J;
Moore, CM;
Smith, SC;
(2017)
Patient-reported outcome (PRO) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments.
[Review].
BJU International
, 120
(4)
pp. 468-481.
10.1111/bju.13896.
|
|
Schoots, IG;
Moore, CM;
Rouvière, O;
(2017)
Role of MRI in low-risk prostate cancer: finding the wolf in sheep's clothing or the sheep in wolf's clothing?
Current Opinion in Urology
, 27
(3)
pp. 238-245.
10.1097/MOU.0000000000000397.
|
|
Simmons, LAM;
Kanthabalan, A;
Arya, M;
Briggs, T;
Barratt, D;
Charman, SC;
Freeman, A;
... Ahmed, HU; + view all
(2017)
The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy.
British Journal of Cancer
, 116
pp. 1159-1165.
10.1038/bjc.2017.57.
|
|
Stavrinides, V;
Parker, CC;
Moore, CM;
(2017)
When no treatment is the best treatment: Active surveillance strategies for low risk prostate cancers.
Cancer Treatment Reviews
, 58
pp. 14-21.
10.1016/j.ctrv.2017.05.004.
|
2016
|
Fulop, NJ;
Ramsay, AI;
Vindrola-Padros, C;
Aitchison, M;
Boaden, RJ;
Brinton, V;
Clarke, CS;
... Morris, S; + view all
(2016)
Reorganising specialist cancer surgery for the twenty-first century: a mixed methods evaluation (RESPECT-21).
Implementation Science
, 11
, Article 155. 10.1186/s13012-016-0520-5.
|
|
|
Johnston, EW;
Pye, H;
Bonet Carne, E;
Panagiotaki, E;
Patel, D;
Galazi, M;
Heavey, S;
... Punwani, S; + view all
(2016)
INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer.
BMC Cancer
, 16
(816)
10.1186/s12885-016-2856-2.
|
|
Martinez de Pinillos Bayona, A;
Moore, CM;
Loizidou, M;
MacRobert, AJ;
Woodhams, JH;
(2016)
Enhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisation.
International Journal of Cancer
, 138
(5)
pp. 1049-1057.
10.1002/ijc.29510.
|
 |
|
Moore, CM;
Taneja, SS;
(2016)
Integrating MRI for the diagnosis of prostate cancer.
Current Opinion in Urology
, 26
(5)
pp. 466-471.
10.1097/MOU.0000000000000323.
|
|
|
Shah, TT;
Peters, M;
Kanthabalan, A;
McCartan, N;
Fatola, Y;
van Zyp, JVDV;
van Vulpen, M;
... Ahmed, HU; + view all
(2016)
PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure.
Prostate Cancer and Prostatic Diseases
, 19
(3)
pp. 311-316.
10.1038/pcan.2016.23.
|
2015
|
Azzouzi, AR;
Barret, E;
Bennet, J;
Moore, C;
Taneja, S;
Muir, G;
Villers, A;
... Emberton, M; + view all
(2015)
TOOKAD (R) Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer.
World Journal of Urology
, 33
(7)
pp. 945-953.
10.1007/s00345-015-1505-8.
|
|
|
Hu, Y;
Gibson, E;
Ahmed, HU;
Moore, CM;
Emberton, M;
Barratt, DC;
(2015)
Population-based prediction of subject-specific prostate deformation for MR-to-ultrasound image registration.
Medical Image Analysis
, 26
(1)
pp. 332-344.
10.1016/j.media.2015.10.006.
|
|
|
Latifoltojar, A;
Dikaios, N;
Ridout, A;
Moore, C;
Illing, R;
Kirkham, A;
Taylor, S;
... Punwani, S; + view all
(2015)
Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate.
Prostate Cancer and Prostatic Disease
, 18
pp. 242-351.
10.1038/pcan.2015.33.
|
|
|
Moore, CM;
Azzouzi, A-R;
Barret, E;
Villers, A;
Muir, GH;
Barber, NJ;
Bott, S;
... Emberton, M; + view all
(2015)
Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy.
BJU International
, 116
(6)
pp. 888-896.
10.1111/bju.12816.
|
|
2014
|
Donaldson, IA;
Alonzi, R;
Barratt, D;
Barret, E;
Berge, V;
Bott, S;
Bottomley, D;
... Ahmed, HU; + view all
(2014)
Focal Therapy: Patients, Interventions, and Outcomes-A Report from a Consensus Meeting.
Eur Urol
, 67
(4)
pp. 771-777.
10.1016/j.eururo.2014.09.018.
|
 |
|
Willis, SR;
Ahmed, HU;
Moore, CM;
Donaldson, I;
Emberton, M;
Miners, AH;
van der Meulen, J;
(2014)
Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis.
BMJ Open
, 4
(6)
, Article e004895. 10.1136/bmjopen-2014-004895.
|
|
